Expression of human apolipoprotein A-I/C-III/A-IV gene cluster in mice induces hyperlipidemia but reduces atherogenesis

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 20, Issue 10, 2000, Pages 2267-2274

  Vergnes, Laurent ^a   Baroukh, Nadine ^a   Ostos, Maria A ^a   Castro, Graciela ^b   Duverger, Nicolas ^c   Nanjee, M Nazeem ^e   Najib, Jamila ^b   Fruchart, Jean Charles ^b   Miller, Norman E ^e   Zakin, Mario M ^a   Ochoa, Alberto ^a,d  

^a INSTITUT PASTEUR   (France)

^b INSTITUT PASTEUR DE LILLE   (France)

^c SANOFI   (France)

^d CEMAGREF   (France)

^e QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Atherosclerosis; Cholesterol; Hypertriglyceridemia; Lipoproteins; Transgenic mice

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN A4; APOLIPOPROTEIN B48; APOLIPOPROTEIN C3; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROGENESIS; CONTROLLED STUDY; FEMALE; GENE CLUSTER; GENE EXPRESSION REGULATION; HYPERLIPIDEMIA; LIPID METABOLISM; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; TRANSGENIC MOUSE;

EID: 0033790445     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.20.10.2267     Document Type: Article

References (32)

1. Apolipoprotein multigene family: Tandem organization of human apolipopmtein AI, CIII, and AIV genes
2. Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI
3. Apolipoprotein AI transgene corrects apolipoprotein E deficiency-induced atherosclerosis in mice
4. Lack of apoA-I is not associated with increased susceptibility to atherosclerosis in mice
5. Lack of apolipoprotein A-I in human apolipoprotein B transgenic mice results in greater susceptibility to diet-induced atherosclerosis
6. Hypertriglyceridemia as a result of human apo CIII gene expression in transgenic mice
7. Chylomicronemia due to apolipoprotein C-III overexpression in apolipoprotein E-null mice
8. Decreased early atherosclerosis lesions in hypertriglyceridemic mice expressing cholesteryl ester transfer protein transgene
9. A mouse model with features of familial combined hyperlipidemia
10. Protection against atherogenesis in mice mediated by human apolipoprotein A-IV
11. Reduced aortic lesions and elevated high density lipoprotein levels in transgenic mice overexpressing mouse apolipoprotein A-IV
12. Intestinal expression of the human ApoAI gene in transgenic mice is controlled by a DNA region 3' to the gene in the promoter of the adjacent convergently transcribed ApoCIII gene
13. The apolipoprotein A-I/C-III/A-IV gene cluster: apoC-III and apoA-IV expression is regulated by two common enhancers
14. The -700/-310 fragment of the apolipoprotein A-IV gene combined with the -890/-500 apolipoprotein C-III enhancer is sufficient to direct a pattern of gene expression similar to that for the endogenous apolipoprotein A-IV gene
15. Co-regulation of apo A-I, apo C-III and apo A-IV gene expression in human intestinal biopsies
16. 3
17. Overexpression of human apolipoprotein C-III in transgenic mice results in an accumulation of apolipoprotein B48 remnants that is corrected by excess apolipoprotein E
18. Intestinal expression of human apolipoprotein A-IV in transgenic mice fails to influence dietary lipid absorption or feeding behavior
19. Regulation of the human apolipoprotein A-IV gene expression in transgenic mice
20. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E
21. Human apolipoproteins AI, AII, CII and CIII: cDNA sequences and mRNA abundance
22. Cholesterol efflux, lecithin-cholesterol acyltransferase activity, and pre-β particle formation by serum from human apolipoprotein A-I and apolipoprotein A-I/apolipoprotein A-II transgenic mice consistent with the latter being less effective for reverse cholesterol transport
23. Sequential ultracentrifugation micromethod for separation of serum lipoproteins and assays of lipids, apolipoproteins, and lipoprotein particles
24. Early incorporation of cell-derived cholesterol into pre-beta-migrating high-density lipoprotein
25. Quantitative assessment of atherosclerotic lesions in mice
26. Apolipoprotein gene expression in the rabbit: Abundance, size, and distribution of apolipoprotein mRNA species in different tissues
27. Acute effects of intravenous infusion of apoA1/phosphatidycholine discs on plasma lipoproteins in humans
28. Quantitation of apolipoprotein A-IV in human plasma using a competitive enzyme-linked immunosorbent assay
29. Nature of the enhancement of lecithin-cholesterol acyltransferase reaction by various apolipoproteins
30. Protective effect of high density lipoprotein associated paraoxonase: Inhibition of the biological activity of minimally oxidized low density lipoproteins
31. High-density lipoproteins differentially modulate cytokine-induced expression of E-selectin and cyclooxygenase-2